FDA recall Z-1809-2018

Tosoh Bioscience Inc · Class II · device

Product

Tosoh ST AIA-PACK HbA1c, HbA1c Reagent, Pt. No. 025218 The device is designed for In Vitro Diagnostic Use Only for the quantitative measurement for percent concentration of Hemoglobin A1c (HbA1c) in EDTA whole blood on Tosoh AIA System Analyzer. HbA1c measurement is used in the management and treatment of diabetes.

Reason for recall

The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.

Distribution

USA (nationwide) Distribution including PR and to the states of : AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.

Key facts

Status
Terminated
Initiation date
2018-03-05
Report date
2018-05-23
Termination date
2020-06-16
Voluntary/Mandated
Voluntary: Firm initiated
Location
Grove City, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1809-2018